Moderna Inc (MRNA)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -4,714,000 -3,466,000 1,207,000 4,784,000 8,362,000 11,765,000 14,055,000 14,638,000 12,202,000 7,061,000 3,495,000 598,000 -747,000 -597,269 -487,484 -505,424 -514,000 -532,123
Total assets US$ in thousands 18,426,000 19,450,000 21,884,000 24,125,000 25,858,000 26,056,000 26,043,000 27,609,000 24,669,000 20,923,000 16,153,000 12,694,000 7,337,000 4,650,870 3,486,010 2,067,540 1,589,420 1,590,900 1,685,280 1,806,210
ROA -25.58% -17.82% 5.52% 19.83% 32.34% 45.15% 53.97% 53.02% 49.46% 33.75% 21.64% 4.71% -10.18% -12.84% -13.98% -24.45% -32.34% -33.45%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $-4,714,000K ÷ $18,426,000K
= -25.58%

To analyze Moderna Inc's return on assets (ROA) based on the provided data, we observe a declining trend in ROA over the last eight consecutive quarters. In Q1 2022, the ROA was at its peak at 53.02%, indicating that the company was generating a substantial return on its assets. However, the ROA began to decline thereafter, with negative ROA figures recorded in the most recent two quarters.

The significant drop in ROA from 53.02% in Q1 2022 to -25.58% in Q4 2023 raises concerns regarding the company's ability to efficiently utilize its assets to generate profits. This decline could be attributed to various factors such as increased operating expenses, lower revenue generation, or ineffective asset management.

The negative ROA values in the last two quarters raise additional red flags as it indicates that the company is experiencing losses rather than generating profits from its assets. Investors and stakeholders may view this trend unfavorably as it suggests a deterioration in the company's overall financial performance and efficiency in utilizing its assets.

In conclusion, Moderna Inc's declining ROA trend, culminating in negative values in the most recent quarters, indicates challenges in optimizing asset utilization and profitability. Further analysis of the company's financial and operational performance is advisable to understand the underlying reasons for the decreasing ROA and to assess the company's future financial prospects.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Return on Assets (ROA) (Quarterly Data)